Mark C. Schneyer, EVP, CFO: Acadia Pharmaceuticals ACAD Sell · Filed 24/08/20

Trade details

Type: Insider sale
Amount: $148,720.24
Shares · price: 9,733 sh · $15.28 a share
Held after: 43,735 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Mark C. SchneyerEVP, CFO
Trade date: 24/08/19
Filed: 24/08/20
Days to filing: 1 days

Sold 18.2% of holdings

Share of holding sold: 18.2%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/07/20~24/09/18

Mark C. Schneyer's recent trades

Mark C. SchneyerEVP, CFO
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 plan
Acadia Pharmaceuticals
ACAD
$158.8K
5,849 sh
$158.8K
Filed 08/05
Traded 08/05
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$76.4K
3,506 sh
$76.4K
Filed 05/05
Traded 05/04
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$60.1K
2,709 sh
$60.1K
Filed 04/07
Traded 04/07
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$89.7K
4,177 sh
$89.7K
Filed 03/26
Traded 03/25
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$68.7K
3,171 sh
$68.7K
Filed 03/26
Traded 03/26